Vyepti Pregnancy Registry: A prospective, comparative cohort study of maternal, fetal and infant safety in pregnant women exposed to eptinezumab in the United States First published 18/02/2026 Last updated 19/02/2026 EU PAS number:EUPAS1000000936 Study Ongoing